Delivery Order SPE2DX22D0129-SPE2D826F0BDL
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,358.70 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,177.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,123.51 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20,927.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,078.45 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 11, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The company,...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 14, 2025. This firm fixed price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,089.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,800 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 1, 2025, with an ultimate completion date of November 3, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle through...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0BDLDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $18,070.38 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. Under this delivery order and the underlying IDC, AmerisourceBergen supplies pharmaceuticals spanning multiple therapeutic domains, including brand-name and generic medications, vaccines, specialty treatments, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders with firm fixed pricing demonstrates its capability to meet federal procurement requirements efficiently across varying transaction values. This contract vehicle enables flexible pharmaceutical support globally for military healthcare programs, positioning AmerisourceBergen as a key vendor within the DLA's pharmaceutical prime vendor network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 11/10/25 |